Veranex Biopharma: Where Therapies, Diagnostics, and Delivery Converge
Advance your solutions with the Innovation CRO. Integrate product development through commercialization to deliver next-generation therapies to patients faster.
The Biopharma Landscape Has Shifted
Convergent therapies are rewriting the rules of development and commercialization. Device-intensive cell and gene therapies, companion diagnostics, biologics paired with novel delivery systems, and combination products all require new approaches, new solutions.Product development
programs
Preclinical & clinical
projects
Cross-disciplinary
experts
Enterprise value
fueled
Why Trust Us
Veranex is the only partner uniting an expert team of design, development, and commercialization for Biopharma solutions.
Veranex turns vision into velocity and measurable patient benefit. Our experts are solution-engineers and power your solutions to the next stage. As you move into clinical research, our biometrics and safety teams help you generate the evidence required for approval and market entry. That is the Innovation CRO advantage Veranex provides.
What We Do
Leverage the full capabilities of Veranex, the Innovation CRO
Combination Products (Drug–Device–Biologic)
Navigate Part 4 CGMP and blended design/quality systems with teams fluent in drug, device, and biologic requirements, so the operating system fits the product and not the other way around.
Drug Delivery Systems
From platform autoinjectors to novel drug delivery systems, we couple HFE, device engineering, and regulatory strategy to de-risk usability, dose accuracy, and manufacturability.
The Biometrics Angle
Clinical Trials demand biometrics and safety teams that translate site data into regulatory-ready evidence. Disciplined data management, biostatistics, pharmacovigilance, and medical writing across Phases I–IV. Create the bridge from promising science to successful submission.
Turn Promising Science into Regulatory-Ready Proof.
That next step is clinical trials, where disciplined data management, statistics, pharmacovigilance, and medical writing make a difference. Work with the biometrics experts that power the biggest CROs (behind the scenes).
Clinical Trials for Drugs & Biologics
Our biometrics & safety team delivers trials across Phases I–IV in Dermatology, Respiratory, Oncology, Infectious Disease, and Cardiovascular by translating site data into regulatory-ready evidence with disciplined data management, statistics, pharmacovigilance, and medical writing.
Clinical Data Management
Robust Data Management & EDC Solutions
Design CRFs and pipelines that capture clean, analysis-ready data using CDISC SDTM and ADaM with end-to-end traceability so you can submit to regulatory bodies with confidence. Leverage today’s best EDC systems to balance capability and cost.
Pharmacovigilance
Drug Safety at Scale
End-to-end case intake, processing, signal detection, and aggregate reporting in line with FDA, EU GVP and global expectations—supporting benefit-risk throughout development and post-authorization.
Biostatistics
Biostatistical Consulting & Full Execution
From sample size estimations and advanced statistical designs to detailed SAPs. We plan and analyze with clear objectives, estimands, and sensitivity analyses that withstand regulatory scrutiny and inform decision-making.
Medical Writing
Scientific and Medical Writing Solutions
Convert complex results into submission-ready narratives and CSRs structured to ICH E3, ensuring clarity, consistency, and auditability across modules. Present your results in powerful ways.
Not every CRO is
built for innovation.
Veranex is.
Scale from molecule to market, including the device.
Your therapy may require delivery, monitoring, or a diagnostic. We build and de-risk those solutions.
- Concept development through clinical-ready builds
- Device-specific regulatory, preclinical, and clinical
- Commercial strategy and market access
All integrated into one team aligned to your goals.




